BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11548253)

  • 1. [Hepatitis B markers in southern Altaĭ inhabitants of the village of Mendur-Sokkon (the Republic of Altaĭ). HBsAg subtyping in hepatitis B virus isolates with monoclonal antibodies].
    Netesova IG; Swenson PD; Osipova LP; Kiselev NN; Posukh OL; Cherepanova NS; Kazakovtseva MA; Kashinskaia IuO; Netesov SV
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (2):29-33. PubMed ID: 11548253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic variability of hepatitis B virus isolates among population of Shuryskarsky area of Yamal-Nenets autonomous region].
    Manuĭlov VA; Netesova IG; Osipova LP; Shustov AV; Baiandin RB; Kochneva GV; Netesov SV
    Mol Gen Mikrobiol Virusol; 2005; (4):30-4. PubMed ID: 16334223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of HBsAg subtypes in Western Siberian part of Russia.
    Netesova IG; Swenson PD; Osipova LP; Gubina MA; Posukh OL; Netesov SV
    J Med Virol; 2003 Oct; 71(2):183-7. PubMed ID: 12938191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus markers in anti-HBc only positive individuals.
    Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
    J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.
    Ye X; Li T; Xu X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Blood Transfus; 2017 Jan; 15(1):6-12. PubMed ID: 27416568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].
    Aydın N; Kırdar S; Uzun N; Eyigör M; Sayan M
    Mikrobiyol Bul; 2016 Oct; 50(4):535-543. PubMed ID: 28124958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
    Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
    Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.
    Mueller A; Stoetter L; Kalluvya S; Stich A; Majinge C; Weissbrich B; Kasang C
    BMC Infect Dis; 2015 Sep; 15():386. PubMed ID: 26399765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study.
    Liu J; Zhang S; Wang Q; Shen H; Zhang M; Zhang Y; Yan D; Liu M
    Lancet Infect Dis; 2016 Jan; 16(1):80-86. PubMed ID: 26268687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S; Singh S
    BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
    Argaw B; Mihret A; Aseffa A; Tarekegne A; Hussen S; Wachamo D; Shimelis T; Howe R
    BMC Infect Dis; 2020 Jul; 20(1):528. PubMed ID: 32698884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis B infections among blood donors in Lao PDR.
    Jutavijittum P; Andernach IE; Yousukh A; Samountry B; Samountry K; Thammavong T; Keokhamphue J; Toriyama K; Muller CP
    Vox Sang; 2014 Jan; 106(1):31-7. PubMed ID: 23931585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z; Milani S; Sharifi Z
    Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of hepatitis B surface antigen seroreversion after corticosteroid treatment in patients with previous hepatitis B virus exposure.
    Wong GL; Wong VW; Yuen BW; Tse YK; Yip TC; Luk HW; Lui GC; Chan HL
    J Hepatol; 2020 Jan; 72(1):57-66. PubMed ID: 31499132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.
    Romanò L; Velati C; Cambiè G; Fomiatti L; Galli C; Zanetti AR;
    Blood Transfus; 2013 Apr; 11(2):281-8. PubMed ID: 23399361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
    Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
    S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population.
    Roman S; Tanaka Y; Khan A; Kurbanov F; Kato H; Mizokami M; Panduro A
    J Med Virol; 2010 Sep; 82(9):1527-36. PubMed ID: 20648606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.
    Baghbanian M; Halvani M; Roghani HS; Lotfi MH; Yazdi MF; Vahedian-Ardakani HA
    Arq Gastroenterol; 2016; 53(3):175-9. PubMed ID: 27438423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus screening in contacts of blood donors with antibodies against core protein (anti-HBC), but without surface antigen (HBsAg).
    Fortes HM; Ribeiro LC; Perazolo GF; Souto FJ
    Mem Inst Oswaldo Cruz; 2006 Mar; 101(2):195-9. PubMed ID: 16830712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.